Realizing the Potential of Digital Measures in the Shift Towards Value-based Care
The shift towards value-based care in healthcare has renewed interest in using digital measures such as [...]
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
This webinar delves into the dynamic landscape of COAs, examining their historical use and significance, current uses and best practices, and making a case for greater standardization in their implementation.
Swoop Launches AI Tool for Medication Adherence Predictive Targeting
Swoop, a prominent provider of custom audiences for the pharmaceutical and life sciences industry, has launched [...]
Shortening Mental Health Treatment Waiting Times Could Save NHS Millions and Improve Patient Outcomes
What You Need to Know: Shortening treatment and waiting times for mental health conditions from 12 months to three could [...]
Medtronic’s Inceptiv System: A New Auto-Adjusting Spinal Cord Stimulator Receives EU Approval
Medtronic has developed a spinal cord stimulator called the Inceptiv system, which alleviates discomfort caused by movements shifting the position [...]
Cellares Secures $255M in Series C Round of Funding
Cellares, a cell therapy manufacturer based in South San Francisco, announced a $255 million series C investment round to finish [...]
Advancements in Healthcare: The Influential Roles of Artificial Intelligence and Data Science
The last decade in healthcare has seen notable advancements due to artificial intelligence (AI), particularly data science. By using data-driven [...]
FDA Approves Ipsen’s Ultra-Rare Bone Disease Drug Sohonos
The Food and Drug Administration (FDA) has approved Ipsen Pharmaceuticals' Sohonos, a drug designed to treat fibrodysplasia ossificans progressiva (FOP), [...]
Federal Appeals Court Restricts Access to Abortion Pill Mifepristone
A federal appeals court has ruled to restrict access to the abortion pill mifepristone but has not removed it from [...]
FDA Accelerates Review of HuidaGene’s Treatment for Inherited Blindness
The US Food and Drug Administration (FDA) has granted HuidaGene Therapeutics a rare pediatric disease designation (RPDD) to accelerate the [...]
Sarepta Therapeutics Begins Dosing Duchenne Patients with Newly Approved Gene Therapy
Sarepta Therapeutics has started dosing Duchenne muscular dystrophy patients with its recently approved gene therapy, Elevidys, and plans to serve [...]
FDA Approves Verrica Pharmaceuticals’ Ycanth
The U.S. Food and Drug Administration (FDA) approved Verrica Pharmaceuticals Inc.'s treatment Ycanth for a viral skin infection known as [...]
Peterson Center on Healthcare Launches Institute to Evaluate Digital Health Technologies
The Peterson Center on Healthcare has launched the Peterson Health Technology Institute (PHTI). The PHTI is a nonprofit organization dedicated [...]
FDA Approves AstraZeneca’s Beyfortus
The Food and Drug Administration has approved an AstraZeneca-developed monoclonal antibody, Beyfortus, in an effort to protect infants and young [...]
Will the Medicare Price Negotiation Revamp Sufficiently Appease Pharma Companies?
The Centers for Medicare & Medicaid Services (CMS) amendments to its drug pricing negotiation program will unlikely deter past, current, [...]
Minimizing the Impact of Cross-Cultural Differences in COA Translations
ICON's COA Linguistic Validation Leaders highlight the importance of Linguistic Validation and how equivalence should be a key focus during the development of Clinical Outcome Assessment translations.
Will 2023 Be the Year AI Disrupts Healthcare?
Before we get to 2023, let’s talk about 2022—specifically about a technology that DIDN’T fulfill its promise last year: [...]
Measuring the intangible- what is the true value of a “patient centric” initiative
In this webinar, brought to you by the company behind A Life in a Day, patient centricity experts will draw from their own experiences to debate questions around how and why to measure these initiatives. Is it important to measure impact and prove outcomes, or is it enough to improve the patient experience for its own sake? Is it even possible to create meaningful measurements for patient centric activities, and if so, what do those measurements look like?
A Journey without a Map: Building an Oncology Powerhouse Where Innovation Thrives
What does it take to deliver the next generation of cancer therapies? And how to stay ahead in a field that’s constantly evolving? These are the questions Astellas’ leaders have been answering during their decade-long journey to build an oncology powerhouse from the ground up. Today, oncology is the company’s largest therapy area of strategic focus and investment and the lessons learned are changing the face of innovation in oncology and beyond.
Podcast Q&A: Evidence Generation Planning
Experts answer questions on evidence generation planning for clinical and commercial success and improvement of patient outcomes.
Podcast Q&A: Renee Willmon on Health Storylines
Join an industry expert as she answers questions on Health Storylines, a disease-agnostic and customizable platform that connects healthcare stakeholders to engaged patients.
Podcast Q&A: Optimizing Real-World Evidence for Maternal and Neonatal Outcomes
This podcast segment features the Q&A from HealthCore's webinar from April 9, 2022 which featured an expert panel of health [...]
Survey Finds Increasing Interest in Patient-Reported Data from Outcomes-Based Contracts
A new survey conducted by Avalere Health suggests rising interest among payers to generate patient-reported data through outcomes-based contracts, according [...]
